Critical Survey: Nanovibronix (NASDAQ:FEED) vs. Curaleaf (OTCMKTS:CURLF)

Nanovibronix (NASDAQ:FEED) and Curaleaf (OTCMKTS:CURLF) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk.

Earnings & Valuation

This table compares Nanovibronix and Curaleaf”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$1.93 million	0.21	-$18.18 million	($117.28)	-0.00
Curaleaf	$1.27 billion	1.83	-$231.07 million	($0.13)	-76.54

Nanovibronix has higher earnings, but lower revenue than Curaleaf. Curaleaf is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and target prices for Nanovibronix and Curaleaf, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Curaleaf	0	0	2	3	3.60

Profitability

This table compares Nanovibronix and Curaleaf’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-1,093.61%	-60.73%	-48.48%
Curaleaf	-2.62%	-0.88%	-0.26%

Insider and Institutional Ownership

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 0.0% of Curaleaf shares are owned by institutional investors. 12.2% of Nanovibronix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Nanovibronix has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500. Comparatively, Curaleaf has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500.

Summary

Curaleaf beats Nanovibronix on 10 of the 14 factors compared between the two stocks.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.

About Curaleaf

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.